Fig. 2From: Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohortEvolution of disease activity and functional disability over 10 years. A Change in DAS28-CRP. B Proportion of disease activity categories defined by DAS28-CRP. C Change in CDAI. D Proportion of disease activity categories defined by CDAI. E Change in HAQBack to article page